Your browser doesn't support javascript.
loading
Ultrasound-Guided Prolotherapy for Acromial Enthesopathy and Acromioclavicular Joint Arthropathy: A Single-Arm Prospective Study.
Hsieh, Pei-Chun; Chiou, Hong-Jen; Wang, Hsin-Kai; Lai, Yi-Chen; Lin, Yung-Hui.
Affiliation
  • Hsieh PC; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chiou HJ; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Wang HK; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Lai YC; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Lin YH; School of Medicine, National Defense Medical Center, Taipei, Taiwan.
J Ultrasound Med ; 38(3): 605-612, 2019 Mar.
Article in En | MEDLINE | ID: mdl-30171616
OBJECTIVES: Prolotherapy is an injection-based complementary treatment for various musculoskeletal diseases. The aim of this study was to evaluate the therapeutic efficacy of ultrasound-guided prolotherapy in the treatment of acromial enthesopathy and acromioclavicular joint arthropathy. METHODS: Thirty-one patients with chronic moderate-to-severe shoulder pain were recruited from September 2015 to September 2017. Ultrasound-guided prolotherapy was performed by injecting 10 mL of a 15% dextrose solution into the acromial enthesis of the deltoid or acromioclavicular joint capsule aseptically. Prolotherapy was given in 2 sessions separated by a 1-month interval. The pretreatment-to-posttreatment change in the pain visual analog scale (VAS) score was recorded as the primary outcome. The mean follow-up duration was 61.8 days. A paired t test was used to assess the difference in pretreatment and posttreatment VAS scores. A univariate logistic regression analysis was conducted to identify the demographic variables associated with substantial pain reduction after the intervention. Substantial pain reduction was defined as a posttreatment VAS score of 3 or less. RESULTS: Twenty of the 31 patients reported substantial pain reduction without adverse effects after the intervention. The mean VAS score reduction ± SD was 4.3 ± 2.6 (pretreatment, 6.8 ± 1.5; posttreatment, 2.5 ± 2.1; P < .01). CONCLUSIONS: Ultrasound-guided prolotherapy with a 15% dextrose solution is an effective and safe therapeutic option for moderate-to-severe acromial enthesopathy and acromioclavicular joint arthropathy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acromioclavicular Joint / Ultrasonography, Interventional / Pain Management / Enthesopathy / Prolotherapy / Joint Diseases Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Ultrasound Med Year: 2019 Document type: Article Affiliation country: Taiwan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acromioclavicular Joint / Ultrasonography, Interventional / Pain Management / Enthesopathy / Prolotherapy / Joint Diseases Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Ultrasound Med Year: 2019 Document type: Article Affiliation country: Taiwan Country of publication: United kingdom